| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NB100-664SS | |||
| Azide and BSA Free | NBP2-81007 | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NB100-648SS | |||
| Azide and BSA Free | NBP2-81006 | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP1-78381SS | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NB100-2381SS | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP3-11437 | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP3-44411 | |||
| BSA Free | NBP2-42385-25ul | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP1-80769-25ul | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP1-88074-25ul | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP2-49064-25ul | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP2-42385 | |||
| BSA Free | NBP2-42385-25ul | |||
![Western Blot: VEGF Antibody (VG1) - BSA Free [NB100-664] - Regorafenib reduced TNBC cell migration & targeted p-STAT3/VEGF-A signaling.(A) Chemical structure of regorafenib. (B,C), Transwell assay (B) & wound-healing assay (C) were performed in TNBC cell lines after regorafenib treatment for 24 h. *p 160) or low VEGF-A (H score < = 160) levels for the indicated time of follow up. Chi-square test indicated a significant difference between VEGF-A high (N = 21) & low (N = 76) patients. Image collected & cropped by CiteAb from the following publication (//pubmed.ncbi.nlm.nih.gov/27364975), licensed under a CC-BY license. Not internally tested by Novus Biologicals.](http://images.novusbio.com/fullsize/nb100-664_mouse-monoclonal-vegf-antibody-vg1-3102024155374.jpg)
![Western Blot: VEGF Antibody (VG1) - BSA Free [NB100-664] - Regorafenib transcriptionally inhibited VEGF-A expression through decreasing binding of STAT3 on promoter of VEGF-A.(A) Top, MDA-MB-231 cells co-transfected w/ a Renilla control vector & plasmids containing firefly luciferase gene driven by wild-type or STAT3 binding site-mutated VEGF-A promoter. After transfection for 48 h, cells treated w/ regorafenib for 24 h. Promoter activity analyzed by luciferase assay after regorafenib treatment. Bottom, MDA-MB-231 cells transfected w/ vector-control or STAT3-overexpression plasmid for 48 h. After , cells further co-transfected w/ Renilla & wild-type VEGF-A promoter & detect promoter activity as mentioned above. *p < 0.05, **p < 0.01. (B) After regorafenib treatment for 24 h, STAT3 binding site fragment detected by PCR in ChIP samples precipitated w/ STAT3 & rabbit IgG control antibodies in MDA-MB-231 cells. (C,D), MDA-MB-231 cells transfected, respectively, w/ control vector or VEGF-A overexpression plasmid (C) or STAT3 overexpression plasmid (D) for 48 h. After transfection, cells treated w/wo regorafenib for 24 h & subjected to WB assay or seeded to Transwell to analyze migration ability. *p < 0.05, **p < 0.01. (E) Cells treated w/ regorafenib at indicated dosages for 24 h & cell lysates analyzed by SHP-1 phosphatase activity assay. *p < 0.05, **p < 0.01. (F) MDA-MB-231 cells pretreated w/ pan-phosphatase inhibitor (left), or specific SHP-1 inhibitor (Middle) for 1 h before regorafenib treatment. Right, MDA-MB-231 cells transfected, respectively, w/ control siRNA or SHP-1 siRNA for 48 h. After transfection, cells treated w/wo regorafenib (10 μM) for 24 h. The protein levels analyzed by WB assay or cells seeded to Transwell to analyze migration ability. *p < 0.05, **p < 0.01. Image collected & cropped by CiteAb from following publication (//pubmed.ncbi.nlm.nih.gov/27364975), licensed under a CC-BY license. Not internally tested by Novus Biologicals.](http://images.novusbio.com/fullsize/nb100-664_mouse-monoclonal-vegf-antibody-vg1-31020241682159.jpg)
![Analysis of a FFPE tissue section of human liver using 1:200 dilution of VEGF antibody [VG1]. The staining was developed using HRP labeled anti-rabbit secondary antibody and DAB reagent, and nuclei of cells were counter-stained with hematoxylin.](http://images.novusbio.com/fullsize/antibody/nb100-664_mouse-monoclonal-vegf-antibody-vg1-immunohistochemistry-paraffin-1211202510571.jpg)
![Analysis of a FFPE tissue section of mouse liver using 1:200 dilution of VEGF antibody [VG1]. The staining was developed using HRP labeled anti-rabbit secondary antibody and DAB reagent, and nuclei of cells were counter-stained with hematoxylin.](http://images.novusbio.com/fullsize/antibody/nb100-664_mouse-monoclonal-vegf-antibody-vg1-immunohistochemistry-paraffin-12112025105832.jpg)
![Immunohistochemistry-Paraffin: VEGF Antibody (VG76e) [NB100-648] - IHC analysis of VEGF in fetal sheep brain tissue. Image courtesy of anonymous customer review.](http://images.novusbio.com/fullsize/VEGF-Antibody-VG76e-Immunohistochemistry-Paraffin-NB100-648-img0004.jpg "Immunohistochemistry-Paraffin: VEGF Antibody (VG76e) [NB100-648] - IHC analysis of VEGF in fetal sheep brain tissue. Image courtesy of anonymous customer review.")
![Western Blot: VEGF Antibody (VG76e) [NB100-648] - Analysis of VEGF in human kidney protein (30ug).](http://images.novusbio.com/fullsize/VEGF-Antibody-VG76e-Western-Blot-NB100-648-img0005.jpg)
![Immunocytochemistry/Immunofluorescence: VEGF Antibody (VG76e) [NB100-648] - Immunofluorescent analysis of VEGF using NB100-648. This image submitted through a verified customer review.](http://images.novusbio.com/fullsize/VEGF-Antibody-VG76e-Immunocytochemistry-Immunofluorescence-NB100-648-img0007.jpg)
![Immunohistochemistry-Paraffin: VEGF Antibody (VG76e) [NB100-648] - IHC-P analysis of VEGF in sheep tonsil using NB100-648. This image was submitted through a verified customer review.](http://images.novusbio.com/fullsize/VEGF-Antibody-VG76e-Immunohistochemistry-Paraffin-NB100-648-img0006.jpg)
![Western Blot: Mouse Monoclonal VEGF Antibody (VG76e) [NB100-648] - Bone lysate homogenate from goats. SDS-PAGE with 0.3 mg of total protein from the homogenate per well. VEGF, NB100-648, was used at a dilution of 1:1000 in TBS Tween and 5% milk powder. The protein was labeled at 40 kDa. Quantification of VEGFA in bone graft in the tibia of intrailiac cellularized goats at different times compared with tibial autograft and untreated bone defect. Evaluation of pre-cellularized graft in iliac crest in the treatment of bone defects in the tibia of goats. G1: cellularized graft for 4 weeks applied to tibial bone defect, G2: cellularized graft for 6 weeks applied to tibial bone defect, G3: cellularized graft for 8 weeks applied to tibial bone defect, G4: tibial autograft and G5: untreated bone defect. All groups were evaluated 120 days after graft implantation. Image from a verified customer review.](http://images.novusbio.com/fullsize/antibody/nb100-648_mouse-monoclonal-vegf-antibody-vg76e-western-blot-2952025142053..jpg)
![Immunohistochemistry: FAT4 Antibody - BSA Free [NBP1-78381] - FAT4 Antibody [NBP1-78381] - Effect of FAT4 knockout on GC tumorigenesis in the nude mice xenograft model. Representative images show IHC staining of BGC-823-KO-NC and BGC-823-FAT4-KO derived xenograft tumors with antibody against FAT4 (NBP1-78381F). Scale bar, 100 um. Image collected and cropped by Citeab from the following publication (//pubmed.ncbi.nlm.nih.gov/29435168/) licensed under a CC-BY license.](http://images.novusbio.com/fullsize/FAT4-Antibody-Knockout-Validated-NBP1-78381-img0005.jpg "<b>Genetic Strategies Validation. </b>Immunohistochemistry: FAT4 Antibody - BSA Free [NBP1-78381] - FAT4 Antibody [NBP1-78381] - Effect of FAT4 knockout on GC tumorigenesis in the nude mice xenograft model. Representative images show IHC staining of BGC-823-KO-NC and BGC-823-FAT4-KO derived xenograft tumors with antibody against FAT4 (NBP1-78381F). Scale bar, 100 um. Image collected and cropped by Citeab from the following publication (//pubmed.ncbi.nlm.nih.gov/29435168/) licensed under a CC-BY license.")
![<b>Genetic Strategies Validation. </b>Immunohistochemistry: FAT4 Antibody [NBP1-78381] - IHC staining of metastatic lung nodules in the nude mice model. Representative images show IHC staining with anti-FAT4 antibody of lung sections from BGC-823-FAT4-KO and BGC-823-KO-NC group mice. FAT4 is positive staining in the lung metastatic tumor nodules of BGC-823-KO-NC group, whereas it negative expresses in BGC-823-FAT4-KO group. Scale bar, 100 i1/4m. Image collected and cropped by Citeab from the following publication (Low FAT4 expression is associated with a poor prognosis in gastric cancer patients. Oncotarget (2018) licensed under a CC-BY license.](http://images.novusbio.com/fullsize/FAT4-Antibody-Knockout-Validated-NBP1-78381-img0006.jpg)
![Immunocytochemistry/Immunofluorescence: FAT4 Antibody [NBP1-78381] - Antibody was tested in A431 cells with FITC (green). Nuclei were counterstained with DAPI (blue).](http://images.novusbio.com/fullsize/FAT4-Antibody-Immunocytochemistry-Immunofluorescence-NBP1-78381-img0003.jpg)
![Immunohistochemistry: FAT4 Antibody [NBP1-78381] - IHC analysis of FAT4 in mouse prostate cancer using DAB with hematoxylin counterstain.](http://images.novusbio.com/fullsize/FAT4-Antibody-Immunohistochemistry-NBP1-78381-img0004.jpg)
![Western Blot: FAT4 Antibody - BSA Free [NBP1-78381] - Expression of selected genes in BCC subsets. (A) Real time PCR for GPR64, FAT4, TMEM98, ALOX5 AP, DUSP4, RAP1A & FN1. The RNA was isolated from Oct4hi, Octmed & Oct4low subsets from MDA-MB-231 stably transfected with pEGFP1-Oct3/4. The results are shown as relative to beta -actin expression with mean ± SD for four independent experiments. (B) Western blots for GPR64, TMEM98, FAT4, RAP1A & FN1 using whole cell extracts expression from Oct4hi, Octmed & Oct4low, isolated as for ‘A’. The results represent four different independent experiments. Image collected & cropped by CiteAb from the following publication (//www.nature.com/articles/s41598-017-18834-5), licensed under a CC-BY license. Not internally tested by Novus Biologicals.](http://images.novusbio.com/fullsize/nbp1-78381_rabbit-polyclonal-fat4-antibody-310202415392572.jpg)
![Western Blot: VEGF Antibody [NB100-2381] - Detection of VEGFA doublet in CSF-IR/VEGFA chimera transfected lysate using.](http://images.novusbio.com/fullsize/VEGFA-Antibody-Western-Blot-NB100-2381-img0005.jpg "Western Blot: VEGF Antibody [NB100-2381] - Detection of VEGFA doublet in CSF-IR/VEGFA chimera transfected lysate using.")
![Immunohistochemistry-Paraffin: VEGF Antibody (VEGF/1063) [NBP2-45235] - Human Tonsil stained with VEGF Monoclonal Antibody (VEGF/1063).](http://images.novusbio.com/fullsize/VEGF-Antibody-VEGF-1063-Immunohistochemistry-Paraffin-NBP2-45235-img0003.jpg "Immunohistochemistry-Paraffin: VEGF Antibody (VEGF/1063) [NBP2-45235] - Human Tonsil stained with VEGF Monoclonal Antibody (VEGF/1063).")
![Immunohistochemistry-Paraffin: VEGF Antibody (VEGF/1063) [NBP2-45235] - Formalin-fixed, paraffin-embedded human Ovarian Carcinoma stained with VEGF Antibody (VEGF/1063).](http://images.novusbio.com/fullsize/VEGF-Antibody-VEGF-1063-Immunohistochemistry-Paraffin-NBP2-45235-img0006.jpg)
![Immunohistochemistry-Paraffin: VEGF Antibody (VEGF/1063) [NBP2-45235] - Formalin-fixed, paraffin-embedded human Tonsil stained with VEGF Antibody (VEGF/1063).](http://images.novusbio.com/fullsize/VEGF-Antibody-VEGF-1063-Immunohistochemistry-Paraffin-NBP2-45235-img0005.jpg)
![Western Blot: Laminin beta 1 Antibody (CL2970) [NBP2-42385] - Analysis of purified human recombinant Laminin-111, Laminin-211, Laminin-411, Laminin-511, Laminin-521 and Laminin-332.](http://images.novusbio.com/fullsize/Laminin-beta-1-Antibody-CL2970-Western-Blot-NBP2-42385-img0016.jpg "Western Blot: Laminin beta 1 Antibody (CL2970) [NBP2-42385] - Analysis of purified human recombinant Laminin-111, Laminin-211, Laminin-411, Laminin-511, Laminin-521 and Laminin-332.")
![Immunohistochemistry-Paraffin: Laminin beta 1 Antibody (CL2970) [NBP2-42385] - Staining of human lymph node shows absence of immunoreactivity in lymphoid cells (negative control).](http://images.novusbio.com/fullsize/Laminin-beta-1-Antibody-CL2970-Immunohistochemistry-Paraffin-NBP2-42385-img0013.jpg)
![Western Blot: Laminin beta 1 Antibody (CL2970) [NBP2-42385] - Analysis in human placenta tissue.](http://images.novusbio.com/fullsize/Laminin-beta-1-Antibody-CL2970-Western-Blot-NBP2-42385-img0014.jpg)
![Immunohistochemistry-Paraffin: Laminin beta 1 Antibody (CL2970) [NBP2-42385] - Staining of human placenta shows moderate immunoreactivity in basement membrane of trophoblast and in endothelium.](http://images.novusbio.com/fullsize/Laminin-beta-1-Antibody-CL2970-Immunohistochemistry-Paraffin-NBP2-42385-img0009.jpg)
![Immunohistochemistry-Paraffin: Laminin beta 1 Antibody (CL2970) [NBP2-42385] - Staining of human pancreas shows moderate positivity in basement membrane of exocrine glands.](http://images.novusbio.com/fullsize/Laminin-beta-1-Antibody-CL2970-Immunohistochemistry-Paraffin-NBP2-42385-img0010.jpg)
![Immunohistochemistry-Paraffin: Laminin beta 1 Antibody (CL2970) [NBP2-42385] - Staining of human endometrium shows immunoreactivity in basement membrane of glandular epithelium.](http://images.novusbio.com/fullsize/Laminin-beta-1-Antibody-CL2970-Immunohistochemistry-Paraffin-NBP2-42385-img0011.jpg)
![Immunohistochemistry-Paraffin: Laminin beta 1 Antibody (CL2970) [NBP2-42385] - Staining of human stomach shows positivity in basement membrane of glandular epithelium.](http://images.novusbio.com/fullsize/Laminin-beta-1-Antibody-CL2970-Immunohistochemistry-Paraffin-NBP2-42385-img0012.jpg)
![Western Blot: Laminin beta 1 Antibody (6I9T4) [NBP3-16392] - Western blot analysis of extracts of Rat lung, using Laminin beta 1 Rabbit mAb (NBP3-16392) at 1:1000 dilution. Secondary antibody: HRP Goat Anti-Rabbit IgG (H+L) at 1:10000 dilution. Lysates/proteins: 25ug per lane. Blocking buffer: 3% nonfat dry milk in TBST. Detection: ECL Basic Kit. Exposure time: 3min.](http://images.novusbio.com/fullsize/Laminin-beta-1-Antibody-6I9T4-Western-Blot-NBP3-16392-img0005.jpg "Western Blot: Laminin beta 1 Antibody (6I9T4) [NBP3-16392] - Western blot analysis of extracts of Rat lung, using Laminin beta 1 Rabbit mAb (NBP3-16392) at 1:1000 dilution. Secondary antibody: HRP Goat Anti-Rabbit IgG (H+L) at 1:10000 dilution. Lysates/proteins: 25ug per lane. Blocking buffer: 3% nonfat dry milk in TBST. Detection: ECL Basic Kit. Exposure time: 3min.")
![Western Blot: Laminin beta 1 Antibody (6I9T4) [NBP3-16392] - Western blot analysis of extracts of Mouse heart, using Laminin beta 1 Rabbit mAb (NBP3-16392) at 1:1000 dilution. Secondary antibody: HRP Goat Anti-Rabbit IgG (H+L) at 1:10000 dilution. Lysates/proteins: 25ug per lane. Blocking buffer: 3% nonfat dry milk in TBST. Detection: ECL Basic Kit. Exposure time: 10s.](http://images.novusbio.com/fullsize/Laminin-beta-1-Antibody-6I9T4-Western-Blot-NBP3-16392-img0004.jpg)
![Western Blot: Laminin beta 1 Antibody (6I9T4) [NBP3-16392] - Western blot analysis of extracts of HepG2 cells, using Laminin beta 1 Rabbit mAb (NBP3-16392) at 1:1000 dilution. Secondary antibody: HRP Goat Anti-Rabbit IgG (H+L) at 1:10000 dilution. Lysates/proteins: 25ug per lane. Blocking buffer: 3% nonfat dry milk in TBST. Detection: ECL Enhanced Kit. Exposure time: 3min.](http://images.novusbio.com/fullsize/Laminin-beta-1-Antibody-6I9T4-Western-Blot-NBP3-16392-img0006.jpg)
![Immunocytochemistry/ Immunofluorescence: Laminin beta 1 Antibody (6I9T4) [NBP3-16392] - Confocal imaging of NIH/3T3 cells using Laminin beta 1 Rabbit mAb followed by a further incubation with Cy3 Goat Anti-Rabbit IgG (H+L) . The cells were counterstained with alpha-Tubulin Mouse mAb followed by incubation with ABflo(R) 488-conjugated Goat Anti-Mouse IgG (H+L) Ab (Green). DAPI was used for nuclear staining (Blue). Objective: 100x.](http://images.novusbio.com/fullsize/nbp3-16392_rabbit-laminin-beta-1-mab-6i9t4-522025126533.jpg)
![Immunocytochemistry/ Immunofluorescence: Laminin beta 1 Antibody (6I9T4) [NBP3-16392] - Confocal imaging of Hep G2 cells using Laminin beta 1 Rabbit mAb followed by a further incubation with Cy3 Goat Anti-Rabbit IgG (H+L) . The cells were counterstained with alpha-Tubulin Mouse mAb followed by incubation with ABflo(R) 488-conjugated Goat Anti-Mouse IgG (H+L) Ab (Green). DAPI was used for nuclear staining (Blue). Objective: 100x.](http://images.novusbio.com/fullsize/nbp3-16392_rabbit-laminin-beta-1-mab-6i9t4-522025125497.jpg)
![Immunocytochemistry/ Immunofluorescence: Laminin beta 1 Antibody (6I9T4) [NBP3-16392] - Confocal imaging of C6 cells using Laminin beta 1 Rabbit mAb followed by a further incubation with Cy3 Goat Anti-Rabbit IgG (H+L) . The cells were counterstained with alpha-Tubulin Mouse mAb followed by incubation with ABflo(R) 488-conjugated Goat Anti-Mouse IgG (H+L) Ab (Green). DAPI was used for nuclear staining (Blue). Objective: 100x.](http://images.novusbio.com/fullsize/nbp3-16392_rabbit-laminin-beta-1-mab-6i9t4-522025125425.jpg)
![Immunohistochemistry-Paraffin: Semaphorin 4C Antibody [NBP1-80769] - Staining of human prostate shows moderate cytoplasmic positivity in smooth muscle cells.](http://images.novusbio.com/fullsize/Semaphorin-4C-Antibody-Immunohistochemistry-Paraffin-NBP1-80769-img0007.jpg "Immunohistochemistry-Paraffin: Semaphorin 4C Antibody [NBP1-80769] - Staining of human prostate shows moderate cytoplasmic positivity in smooth muscle cells.")
![Immunohistochemistry-Paraffin: Semaphorin 4C Antibody [NBP1-80769] - Staining of human placenta shows moderate cytoplasmic positivity in trophoblastic cells.](http://images.novusbio.com/fullsize/Semaphorin-4C-Antibody-Immunohistochemistry-Paraffin-NBP1-80769-img0004.jpg)
![Immunohistochemistry-Paraffin: Semaphorin 4C Antibody [NBP1-80769] - Staining of human duodenum shows moderate positivity in apical membrane in glandular cells.](http://images.novusbio.com/fullsize/Semaphorin-4C-Antibody-Immunohistochemistry-Paraffin-NBP1-80769-img0005.jpg)
![Immunohistochemistry-Paraffin: Semaphorin 4C Antibody [NBP1-80769] - Staining of human skeletal muscle shows no positivity in myocytes as expected.](http://images.novusbio.com/fullsize/Semaphorin-4C-Antibody-Immunohistochemistry-Paraffin-NBP1-80769-img0006.jpg)
![Immunohistochemistry-Paraffin: Semaphorin 4C Antibody [NBP1-80769] - Staining of human placenta shows moderate membranous positivity in trophoblastic cells.](http://images.novusbio.com/fullsize/Semaphorin-4C-Antibody-Immunohistochemistry-Paraffin-NBP1-80769-img0008.jpg)
![Immunohistochemistry-Paraffin: Laminin beta 1 Antibody [NBP1-88074] - Staining of human skeletal muscle shows very weak cytoplasmic positivity in myocytes.](http://images.novusbio.com/fullsize/Laminin-beta-1-Antibody-Immunohistochemistry-Paraffin-NBP1-88074-img0011.jpg "Immunohistochemistry-Paraffin: Laminin beta 1 Antibody [NBP1-88074] - Staining of human skeletal muscle shows very weak cytoplasmic positivity in myocytes.")
![Immunohistochemistry-Paraffin: Laminin beta 1 Antibody [NBP1-88074] - Staining of human pancreas shows no cytoplasmic positivity in exocrine glandular cells as expected.](http://images.novusbio.com/fullsize/Laminin-beta-1-Antibody-Immunohistochemistry-Paraffin-NBP1-88074-img0009.jpg)
![Immunohistochemistry-Paraffin: Laminin beta 1 Antibody [NBP1-88074] - Staining of human tonsil shows no cytoplasmic positivity in non-germinal center cells as expected.](http://images.novusbio.com/fullsize/Laminin-beta-1-Antibody-Immunohistochemistry-Paraffin-NBP1-88074-img0010.jpg)
![Immunocytochemistry/Immunofluorescence: FAT4 Antibody [NBP2-49064] - Staining of human cell line AF22 shows localization to cytosol. Antibody staining is shown in green. Antibody staining is shown in green.](http://images.novusbio.com/fullsize/FAT4-Antibody-Immunocytochemistry-Immunofluorescence-NBP2-49064-img0006.jpg "Immunocytochemistry/Immunofluorescence: FAT4 Antibody [NBP2-49064] - Staining of human cell line AF22 shows localization to cytosol. Antibody staining is shown in green. Antibody staining is shown in green.")
![Immunohistochemistry-Paraffin: FAT4 Antibody [NBP2-49064] - Staining of human parathyroid gland shows moderate positivity in glandular cells.](http://images.novusbio.com/fullsize/FAT4-Antibody-Immunohistochemistry-Paraffin-NBP2-49064-img0011.jpg)
![Immunohistochemistry-Paraffin: FAT4 Antibody [NBP2-49064] - Staining of human cervix, uterine shows weak to moderate cytoplasmic positivity in squamous epithelial cells.](http://images.novusbio.com/fullsize/FAT4-Antibody-Immunohistochemistry-Paraffin-NBP2-49064-img0007.jpg)
![Immunohistochemistry-Paraffin: FAT4 Antibody [NBP2-49064] - Staining of human endometrium shows strong cytoplasmic positivity in glandular cells.](http://images.novusbio.com/fullsize/FAT4-Antibody-Immunohistochemistry-Paraffin-NBP2-49064-img0008.jpg)
![Immunohistochemistry-Paraffin: FAT4 Antibody [NBP2-49064] - Staining of human placenta shows moderate to strong cytoplasmic positivity in trophoblastic cells.](http://images.novusbio.com/fullsize/FAT4-Antibody-Immunohistochemistry-Paraffin-NBP2-49064-img0009.jpg)
![Immunohistochemistry-Paraffin: FAT4 Antibody [NBP2-49064] - Staining of human prostate shows weak to moderate membranous positivity in glandular cells.](http://images.novusbio.com/fullsize/FAT4-Antibody-Immunohistochemistry-Paraffin-NBP2-49064-img0010.jpg)
![Western Blot: Laminin beta 1 Antibody [NBP1-32043] - Various whole cell extracts (30 ug) were separated by 5% SDS-PAGE, and the membrane was blotted with Laminin beta 1 antibody diluted at 1:1000. The HRP-conjugated anti-rabbit IgG antibody (NBP2-19301) was used to detect the primary antibody.](http://images.novusbio.com/fullsize/Laminin-beta-1-Antibody-Western-Blot-NBP1-32043-img0007.jpg "Western Blot: Laminin beta 1 Antibody [NBP1-32043] - Various whole cell extracts (30 ug) were separated by 5% SDS-PAGE, and the membrane was blotted with Laminin beta 1 antibody diluted at 1:1000. The HRP-conjugated anti-rabbit IgG antibody (NBP2-19301) was used to detect the primary antibody.")
![Immunocytochemistry/Immunofluorescence: Laminin beta 1 Antibody [NBP1-32043] - Paraformaldehyde-fixed HeLa, using antibody at 1:100 dilution.](http://images.novusbio.com/fullsize/Laminin-beta-1-Antibody-Immunocytochemistry-Immunofluorescence-NBP1-32043-img0003.jpg)
![Immunohistochemistry-Paraffin: Laminin beta 1 Antibody [NBP1-32043] - Human colon carcinoma, using Laminin beta 1antibody at 1:500 dilution. Antigen Retrieval: Trilogy™ (EDTA based, pH 8.0) buffer, 15min.](http://images.novusbio.com/fullsize/Laminin-beta-1-Antibody-Immunohistochemistry-Paraffin-NBP1-32043-img0004.jpg)
![Western Blot: Laminin beta 1 Antibody [NBP1-32043] - Sample (30 ug of whole cell lysate) A: NIH-3T3 5% SDS PAGE; antibody diluted at 1:1000.](http://images.novusbio.com/fullsize/Laminin-beta-1-Antibody-Western-Blot-NBP1-32043-img0005.jpg)